Your browser doesn't support javascript.
Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
Taghizadeh, Peyman; Salehi, Sadegh; Heshmati, Ali; Houshmand, Seyed Massoud; InanlooRahatloo, Kolsoum; Mahjoubi, Forouzandeh; Sanati, Mohammad Hossein; Yari, Hadi; Alavi, Afagh; Jamehdar, Saeid Amel; Dabiri, Soroosh; Galehdari, Hamid; Haghshenas, Mohammad Reza; Hashemian, Amir Masoud; Heidarzadeh, Abtin; Jahanzad, Issa; Kheyrani, Elham; Piroozmand, Ahmad; Mojtahedi, Ali; Nikoo, Hadi Razavi; Rahimi Bidgoli, Mohammad Masoud; Rezvani, Nayebali; Sepehrnejad, Mehdi; Shakibzadeh, Arash; Shariati, Gholamreza; Seyyedi, Noorossadat; MohammadSaleh Zahraei, Seyed; Safari, Iman; Elahi, Elahe.
  • Taghizadeh P; School of Biology, University College of Science, University of Tehran, Tehran, Iran.
  • Salehi S; Cell and Molecular Biology Department, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
  • Heshmati A; School of Biology, University College of Science, University of Tehran, Tehran, Iran.
  • Houshmand SM; Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • InanlooRahatloo K; School of Biology, University College of Science, University of Tehran, Tehran, Iran.
  • Mahjoubi F; Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • Sanati MH; Department of Medical Biotechnology, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • Yari H; Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology, Tehran, Iran.
  • Alavi A; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Jamehdar SA; Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Dabiri S; Department of Laboratory Sciences, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Galehdari H; Department of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Haghshenas MR; Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Hashemian AM; Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Heidarzadeh A; Faculty of Medicine, Guilan University of Medical Sciences, Guilan, Iran.
  • Jahanzad I; Pars Hospital Laboratory, Rasht, Iran.
  • Kheyrani E; Taban Genetics Laboratory, Tehran, Iran.
  • Piroozmand A; Department of Microbiology and Immunology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
  • Mojtahedi A; Microbiology Department, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
  • Nikoo HR; Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  • Rahimi Bidgoli MM; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Rezvani N; Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Sepehrnejad M; COVID-19 Diagnosis Laboratory, Kashan University of Medical Sciences, Kashan, Iran.
  • Shakibzadeh A; Department of Medical Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Shariati G; Department of Medical Genetics, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Seyyedi N; Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
  • MohammadSaleh Zahraei S; Department of Genetics, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Safari I; School of Biology, University College of Science, University of Tehran, Tehran, Iran. Electronic address: imansafari@ut.ac.ir.
  • Elahi E; School of Biology, University College of Science, University of Tehran, Tehran, Iran. Electronic address: elaheelahi@ut.ac.ir.
Virology ; 562: 63-73, 2021 10.
Article in English | MEDLINE | ID: covidwho-1275757
ABSTRACT
We aimed to describe SARS-CoV-2 strains in Iranians from nine distributed cities infected during two months expanding late 2020 and early 2021 by genotyping known informative single nucleotide in five PCR amplicons. Two variants associated with haplotype H1 (clade G) and nine additional variants associated with other haplotypes were genotyped, respectively, in RNA isolates of 244 and 85 individuals. The variants associated with the H1a (GR) and H1b (GH) haplotypes were most prevalent, indicating a significant change in infection pattern with passage of time. The most important findings were that recombinant genomes and co-infection, respectively, were surmised in 44.7% and 12.9% of the samples extensively genotyped. Partners of many of the recombinations were relatively common strains. Co-existing viruses were among those currently circulating in Iran. In addition to random mutations, co-infection with different existing strains and recombination between their genomes may significantly contribute to the emergence of new SARS-CoV-2 strains.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Recombination, Genetic / Genetic Variation / Genome, Viral / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: Virology Year: 2021 Document Type: Article Affiliation country: J.virol.2021.06.004

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Recombination, Genetic / Genetic Variation / Genome, Viral / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: Virology Year: 2021 Document Type: Article Affiliation country: J.virol.2021.06.004